^
    12ms
    The relevance of the reference range for EGFR testing in non-small cell lung cancer patients. (PubMed)
    Our study highlights that NGS is able to identify a much higher number of actionable EGFR mutations than RT-qPCR approaches, thereby providing many more patients the opportunity to receive targeted EGFR treatments.
    Journal • Retrospective data
    |
    cobas® EGFR Mutation Test v2 • therascreen® EGFR RGQ PCR Kit • EasyPGX® ready MSI • Idylla™ EGFR Mutation Test • therascreen® EGFR Plus RGQ PCR Kit
    over3years
    Qiagen gets CE Mark for Therascreen EGFR Plus RGQ Kit for Non-Small Cell Lung Cancer (Genomeweb)
    "Qiagen said Tuesday that it has obtained the CE mark for the Therascreen EGFR Plus RGQ PCR Kit — an in vitro diagnostic test for EGFR mutation analysis in non-small cell lung cancer — and has launched the assay in 11 countries that accept the designation."
    Launch • European regulatory
    |
    therascreen® EGFR Plus RGQ PCR Kit